# US 2024/0197985 A1 · Audio/tactile input-output and audio control for automated insulin delivery applications > Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt - Number: US 2024/0197985 A1 - Document ID: US20240197985A1 - Status: Published application - Kind: A1 - Application number: 18/528,111 - Filed: 2023-12-04 - Published: 2024-06-20 - Earliest claimed: 2022-12-19 - Assignees: Insulet Corporation - Applicants: Insulet Corporation - Inventors: Rangarajan NARAYANASWAMI - Web page: https://patentgrep.com/patent/US20240197985A1 ## CPC - A61M 5/14248: {of the skin patch type} - G16H 20/17: delivered via infusion or injection - A61M 5/14: Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor - A61M 5/14244: {adapted to be carried by the patient, e.g. portable on the body} - A61M 5/172: electrical or electronic - G06F 16/635: Filtering based on additional data, e.g. user or group profiles - G10L 15/1822: {Parsing for meaning understanding} - G10L 15/22: Procedures used during a speech recognition process, e.g. man-machine dialogue - G16H 40/63: for local operation - A61M 2205/582: by tactile feedback - G06F 40/279: Recognition of textual entities - G10L 2015/223: {Execution procedure of a spoken command} - A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)} - G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA - G06F: ELECTRIC DIGITAL DATA PROCESSING (computer systems based on specific computational models G06N) - G10L: SPEECH ANALYSIS TECHNIQUES OR SPEECH SYNTHESIS; SPEECH RECOGNITION; SPEECH OR VOICE PROCESSING TECHNIQUES; SPEECH OR AUDIO CODING OR DECODING ## Abstract Disclosed are techniques, devices and systems that implement and utilize a voice control application and sound chip circuitry to control operation of a wearable drug delivery device. In addition, a wearable drug delivery device equipped with the sound chip circuitry may be operable to play audio clips that may include content for assisting a user with an initial set up of the wearable drug delivery device, providing messages of encouragement, lullabies for pediatric users, and the like. In addition, the voice control application enables users to control delivery of liquid drugs via a wearable drug delivery device hands-free using voice commands and voice confirmations of actions to be taken by an automated insulin delivery application. ## Claims ### Claim 1 A wearable drug delivery device, comprising: a processor operable to execute programming instructions; communication circuitry coupled to the processor and operable to receive and transmit information; sound chip circuitry including a recording memory, a microphone, a speaker, a processor, and a voice control application, wherein the recording memory, the microphone, the speaker, and the voice control circuitry are coupled to one another and the recording memory is operable to store a plurality of audio clips; and a memory coupled to the processor and operable to store the programming instructions and, wherein the sound chip circuitry is operable to: identify a specific audio clip from the plurality of audio clips stored in the recording memory; and output the specific audio clip via the speaker. ### Claim 2 (depends on 1) The wearable drug delivery device of claim 1, wherein the sound chip is further operable, to: determine a time of day; and use the determined time of day when identifying the specific audio clip from the plurality of audio clips. ### Claim 3 (depends on 1) The wearable drug delivery device of claim 1, wherein the sound chip is further operable, to: determine a location of a controller associated with the voice control application; and use the determined location of the controller when identifying the specific audio clip from the plurality of audio clips. ### Claim 4 (depends on 1) The wearable drug delivery device of claim 1, wherein the sound chip is further operable, to: determine a location of a controller associated with the voice control application; determine a time of day; and use the determined time of day and the determined location of the controller when identifying the specific audio clip from the plurality of audio clips. ### Claim 5 (depends on 1) The wearable drug delivery device of claim 1, wherein the sound chip is further operable, to: receive an indication that a battery of the controller is being recharged; and in response to the received indication, begin the identifying of the specific audio clip from the plurality of audio clips. ### Claim 6 (depends on 1) The wearable drug delivery device of claim 1, wherein the sound chip, prior to identifying the specific audio clip from the plurality of audio clips, is further operable, to: receive an indication that a user selected a record audio function; record audio in response to the received indication of selection of the record audio function; and store the recorded audio in the recording memory with the plurality of audio clips. ### Claim 7 (depends on 1) The wearable drug delivery device of claim 1, wherein the sound chip, prior to identifying the specific audio clip from the plurality of audio clips, is further operable, to: receive an indication that a user selected a record audio function; record audio in response to the received indication of selection of the record audio function; and store the recorded audio in the recording memory with the plurality of audio clips. ### Claim 8 (depends on 1) The wearable drug delivery device of claim 1, wherein the sound chip is further operable, to: receive an unpackaging indication that a package containing the wearable drug delivery device has been opened; and use the unpackaging indication to identify the specific audio clip from the plurality of audio clips, wherein the identified specific audio clip includes instructions related to initializing the wearable drug delivery device for use by the user. ### Claim 9 A wearable drug delivery device, comprising: a processor operable to execute programming instructions; communication circuitry coupled to the processor and operable to receive and transmit information; sound chip circuitry including a microphone, a speaker, and voice control circuitry, wherein the microphone, the speaker and the voice control circuitry are coupled to one another; and a memory coupled to the processor and operable to store the programming instructions, wherein the sound chip circuitry is operable to: receive a voice command indicative of an insulin delivery action to be taken by an automated insulin delivery application; determine the received voice command corresponds to an identified insulin delivery action to be taken by the automated insulin delivery application; output a confirmation request; monitor for receipt of an input that is a confirmation response to the confirmation request; and in response to receipt of the confirmation response, enable the insulin delivery action to be taken by the automated insulin delivery application. ### Claim 10 (depends on 9) The wearable drug delivery device of claim 9, wherein the sound chip circuitry, prior to receiving the voice command indicative of the insulin delivery action, is operable to: determine a verbal input is an activation keyword; and in response to the activation keyword, the voice control circuitry switches from an active listening mode to a full activation mode, wherein the full activation mode includes recognition of keywords that form the voice command indicative of an insulin delivery action. ### Claim 11 (depends on 9) The wearable drug delivery device of claim 9, wherein the sound chip circuitry is further operable to: receive a plurality of signals within the current period of time, wherein each signal of the plurality of signals includes at least the discrete amount of insulin to be delivered by the wearable drug delivery device. ### Claim 12 (depends on 9) The wearable drug delivery device of claim 9, wherein the confirmation request indicates the action to be taken by the automated insulin delivery application and sets the voice control application for receipt of a confirmation input related to the action to be taken by the automated insulin delivery application. ### Claim 13 (depends on 9) The wearable drug delivery device of claim 9, wherein the sound chip circuitry further comprises a natural language understanding module, and the sound chip circuitry is further operable to: call the natural language understanding module for further interpretation and recognition of terms and phrases that form keywords of the voice command indicative of the insulin delivery action and inputs. ### Claim 14 (depends on 9) The wearable drug delivery device of claim 9, wherein the sound chip circuitry, when enabling the insulin delivery action to be taken by the automated insulin delivery application, is further operable to: determine the received voice command corresponds to an identified insulin delivery action based on a recognition result; and forward a signal representing the corresponding insulin delivery action to an AID application for execution. ### Claim 15 A drug delivery system, comprising: a processor operable to execute programming instructions; communication circuitry coupled to the processor and operable to receive and transmit information; sound chip circuitry including at least two of the following: a microphone, a speaker, a vibration device, or voice control circuitry; and a memory coupled to the processor and operable to store the programming instructions, wherein the sound chip circuitry is operable to: receive a voice command indicative of an insulin delivery action to be taken by an automated insulin delivery application; determine the received voice command corresponds to an identified insulin delivery action to be taken by the automated insulin delivery application; output a confirmation request; monitor for receipt of an input that is a confirmation response to the confirmation request; and in response to receipt of the confirmation response, enable the insulin delivery action to be taken by the automated insulin delivery application. ### Claim 16 (depends on 15) The drug delivery system of claim 15, wherein the voice control circuitry of the sound chip circuitry further comprises: a sound chip processor and a voice control application executable by the sound chip processor. ### Claim 17 (depends on 15) The drug delivery system of claim 15, wherein the sound chip circuitry further comprises: a text to speech engine operable to generate the confirmation request. ### Claim 18 (depends on 15) The drug delivery system of claim 15, further comprising: a display device communicatively coupled to the processor, wherein the processor, prior to outputting the audio confirmation request message, is further operable to: cause a display device to present the identified insulin delivery action in a graphical user interface. ### Claim 19 (depends on 15) The drug delivery system of claim 15, further comprises: a display device communicatively coupled to the processor, and wherein the received voice command indicative of an insulin delivery action to be taken is a presentation of a menu of AID actions, and the processor, prior to outputting the audio confirmation request message, is further operable to: present, on the display device, a menu of AID actions populated with a plurality of AID actions that may be selected for implementation; receive a selection of one of the presented AID actions. ### Claim 20 (depends on 15) The wearable drug delivery device controller of claim 15, wherein the processor is further operable to: receive a verbal annotation related to a user impression of a period of time related to a treatment program of the user; categorize the verbal annotation based on an output of a natural language understanding module; store a digital representation of the verbal annotation in memory based on the categorization of the verbal annotation; and use the stored digital representation of the verbal annotation to generate a treatment program recommendation for output to the user.